Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 2, p. 144, doi. 10.1038/cgt.2010.66
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2011 AND VI 18 AND IP 2
Results: 7
1
2
Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 2, p. 100, doi. 10.1038/cgt.2010.56
- By:
- Publication type:
- Article
3
Role of Rac1-dependent NADPH oxidase in the growth of pancreatic cancer.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 2, p. 135, doi. 10.1038/cgt.2010.64
- By:
- Publication type:
- Article
4
Lentiviral transfer of an inducible transgene expressing a soluble form of Gas1 causes glioma cell arrest, apoptosis and inhibits tumor growth.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 2, p. 87, doi. 10.1038/cgt.2010.54
- By:
- Publication type:
- Article
5
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 2, p. 123, doi. 10.1038/cgt.2010.62
- By:
- Publication type:
- Article
6
Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 2, p. 110, doi. 10.1038/cgt.2010.58
- By:
- Publication type:
- Article
7
Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 2, p. 77, doi. 10.1038/cgt.2010.53
- By:
- Publication type:
- Article